Updates

June 19, 2019
Kisqali-Endocrine Therapy Combo Increases Overall Survival In Hormone Receptor-Positive Breast Cancer Patients, Study Shows

A combination of endocrine therapy and the targeted therapy Kisqali (ribociclib) is more effective than endocrine therapy alone at prolonging the survival of ... Read more
June 17, 2019
FDA Approves Herceptin Biosimilar Kanjinti for HER2-positive Breast Cancer

The U.S. Food and Drug Administration (FDA) has approved Amgen and Allergan’s Kanjinti (trastuzumab-anns), a biosimilar to Genentech’s Herceptin (trastuzumab), for all indications of its reference ... Read more
June 14, 2019
Susan G. Komen, Cancer Australia to Co-fund Metastatic BC Research

A new partnership between Susan G. Komen and Cancer Australia will grant a researcher $450,000 over three years to study metastatic breast cancer. Through ... Read more
June 12, 2019
Combining 2 Assessments of Breast Cancer Recurrence Risk May Help Guide Use of Adjuvant Chemotherapy

Adding an assessment of a woman’s clinical risk to Genomic Health‘s genomic test Oncotype DX to estimate the likelihood of breast cancer recurrence may ... Read more
June 11, 2019June 7, 2019
How a $100 Bill Brings Me Peace of Mind

I could smell cleanliness when I opened my front door. Lemon. Pine. The glorious absence of dust. It’s that elusive moment right after my ... Read more

News

Long-term Data Continue to Support Perjeta Regimen for HER2-positive Metastatic Breast Cancer
June 7, 2019
End-of-study data from the CLEOPATRA trial supports the long-term efficacy of Genentech‘s Perjeta (pertuzumab) ...
News

New AI-based Model Outperforms Current Methods of Predicting Breast Cancer Risk
June 5, 2019
Scientists have created a new artificial intelligence (AI)-based model that outperforms current models at ...
News

Chemo Resistance in TNBC Due to Molecular Changes That May Be Treatable, Study Suggests
June 3, 2019
Triple-negative breast cancer (TNBC) cells can become resistant to chemotherapy by temporarily turning on ...
News

Prestige’s HD201, a Biosimilar to Herceptin, Accepted for Review in Europe for HER2-positive BC
May 31, 2019May 31, 2019
The European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) ...
News

FDA Approves Piqray-Faslodex Combo for Some Patients with Advanced Breast Cancer
May 29, 2019May 29, 2019
Breast cancer patients in the U.S. who are receptor positive (HR+), human epidermal growth ...
A Lump in the Road - A Column by Nancy Brier, Columns

The Blonde in the Waiting Room
May 28, 2019May 24, 2019
A young woman weeped. Pretty blond hair swung in front of her face, but ...

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

Keytruda Fails to Improve Overall Survival of Patients with Triple-Negative Breast Cancer, Phase 3 Trial Shows
May 24, 2019
Keytruda (pembrolizumab), Merck‘s anti-PD-1 checkpoint blockade immunotherapy, failed to prolong the overall survival of ...
Treatment Intensity Should Be Personalized in Women with HER2-positive Breast Cancer, Study Says
May 22, 2019
Personalized treatment intensity is crucial to the success of less toxic and demanding therapies ...
Young Women More Likely to Face Aggressive BC Types, But Proper Treatment Improves Outcomes
May 20, 2019
Experimental Antibody Therapy Leads to Significant Responses in HER2-positive Breast Cancer, Phase 2 Trial Shows
May 15, 2019
Here I Am
May 14, 2019May 9, 2019
Radiation Therapy Reduces Chances of Breast Cancer Returning in Women with Early, Hormone-Positive Disease, Trial Shows
May 13, 2019

Kadcyla Approved in US for Some HER2-positive Early Breast Cancer Patients
May 10, 2019
The U.S. Food and Drug Administration (FDA) has extended the use of Genentech‘s Kadcyla (ado-trastuzumab emtansine) ...
SHARE Introduces My MBC & Me App for Metastatic Breast Cancer Patients
May 6, 2019
New Imaging Tool Captures Process That Turns Tumor Cells Malignant in Breast Cancer
May 3, 2019
Walking on Broken Glass
April 30, 2019April 26, 2019

Clinical Trial Will Test Investigational Therapy Targeting ‘Dormant’ Breast Cancer Cells
April 29, 2019April 29, 2019
GlycoMimetics is planning a clinical trial testing its therapy candidate GMI-1359 as a treatment ...
Surgery That Removes All Traces of Breast Cancer Stimulates Protective Anticancer Immune Response, Mouse Study Suggests
April 26, 2019
Liposomal Irinotecan Shows Promising Phase 1 Results in Heavily Treated Breast Cancer Patients
April 24, 2019

News

Antibiotic in Long Use for Leprosy, Clofazimine, May Treat Triple-negative Breast Cancer, Mouse Study Suggests
April 22, 2019
Clofazimine, an antibiotic long used for treating leprosy and tuberculosis, may be repurposed as a ...
News

AstraZeneca Teams with Daiichi Sankyo to Speed Development of HER2-positive Advanced Breast Cancer Therapy
April 17, 2019
AstraZeneca is starting a collaboration with Daiichi Sankyo for the global production and commercialization of ...
A Lump in the Road - A Column by Nancy Brier, Columns

It’s Probably Nothing
April 16, 2019April 15, 2019
It’s probably not back. But if it is, it’ll kill me. Every six months, ...
News

Lynparza Approved in EU to Treat Subset of Advanced Breast Cancer
April 15, 2019
Lynparza (olaparib) tablets have been approved by the European Commission as a standalone treatment ...
News

Surgery Extends Lives of Women with Metastatic Breast Cancer, Study Says
April 12, 2019
Women with HER2-positive breast cancer that has spread to distant organs live longer if ...
News

FDA Approves Ibrance Combo Therapy for Some Male Breast Cancers
April 10, 2019
The U.S. Food and Drug Administration (FDA) has expanded the use of Ibrance (palbociclib) capsules ...
News

Time-Restricted Feeding May Cut Tumor Risk in Obese Women, Mouse Study Suggests
April 8, 2019
A preliminary study in mice suggests that when a person eats, and not what ...
News

Faslodex-Arimidex Improves Survival in Post-menopausal Women with Advanced BC, Trial Shows
April 5, 2019
First-line treatment with Arimidex (anastrozole) plus Faslodex (fulvestrant) prolongs the lives of post-menopausal women ...
News

FDA Proposes New Policies to Modernize, Improve Quality of Mammography Screenings
April 3, 2019
The U.S. Food and Drug Administration (FDA) has proposed a set of new policies ...
A Lump in the Road - A Column by Nancy Brier, Columns

Doc, You’re a Downer. Let Me Revel in My 5-Year Mark
April 2, 2019March 29, 2019
I met a guy at a party. At first, he was quite the charmer, ...
News

Breast Cancer Survivors Weigh in on Ways to Reduce the Financial Burden of the Disease
April 1, 2019
A qualitative study has proposed nine recommendations from breast cancer survivors about how to ...
News

Frying Oil Reheated Often, Like in Deep Frying, Seen to Promote Breast Cancer’s Spread in Animal Study
March 29, 2019
Frying oil that has repeatedly been reheated to high temperatures — as can take ...
News

Molecular Patterns of Breast Cancer May Predict Chance of Relapse Up to 20 Years Later
March 27, 2019
Screening a woman’s breast cancer for certain genetic and molecular patterns may be used ...
News

Estrogen May Trigger Brain Metastasis in Triple-negative Breast Cancer, Study Shows
March 25, 2019
Estradiol, a type of estrogen and the major female hormone, may drive the spread ...
News

AI Matches Radiologists’ Skill at Detecting Breast Cancer on Mammograms
March 22, 2019
An artificial intelligence (AI) system based on deep learning algorithms is able to detect ...
News

CHMP Favors EU Approval of Lynparza for Some Advanced Breast Cancers
March 20, 2019
The Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines ...
A Lump in the Road - A Column by Nancy Brier, Columns

Reaching the Double Nickel
March 19, 2019March 18, 2019
I shivered in the parking lot at my kid’s school with four other moms. ...
News

Vitamin C Might Reverse Stress-induced Driver of Breast Cancer, Study Says
March 18, 2019
Chronic stress and the consequent release of the stress hormone epinephrine may help breast ...

June 22, 2018June 22, 2018

Clinical Trial of Tamoxifen-based Gel in Reducing Breast Density Recruiting in US, EU

News

The ability of a gel containing a tamoxifen-byproduct to reduce breast density — associated with an increased risk of breast cancer — is now being evaluated in a recruiting Phase 3 clinical trial. Approximately half of women in ... Read more

Subscribe to our mailing list

Pin It on Pinterest